The amount of Aβ(1–42) in CSF gradually increases with age, and the CSF of familial Alzheimer's disease (AD) patients, who possesses genetic mutations in amyloid precursor protein (APP), contain higher concentrations of Aβ(1–42) when compared to healthy persons. Here, APP is linked to Alzheimer disease.